{"id":51040,"date":"2022-11-18T16:02:32","date_gmt":"2022-11-18T15:02:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/"},"modified":"2022-11-18T16:02:32","modified_gmt":"2022-11-18T15:02:32","slug":"arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/","title":{"rendered":"ArrePath Appoints Connor Coley, PhD, and Paul Hergenrother, PhD, to Scientific Advisory Board"},"content":{"rendered":"<div>\n<p>\n\u00a0\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221118005045\/en\/1641767\/5\/ArrePath_640x360_CAN_USE_THIS.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221118005045\/en\/1641767\/21\/ArrePath_640x360_CAN_USE_THIS.jpg\"><\/a><\/p>\n<p>PRINCETON, N.J.&#8211;(BUSINESS WIRE)&#8211;ArrePath today announced that it has appointed two new members to its Scientific Advisory Board (SAB): Connor Coley, PhD, Henri Slezynger (1957) Career Development Assistant Professor in Chemical Engineering at MIT, and Paul Hergenrother, PhD, Kenneth L. Rinehart Jr. Endowed Chair in Natural Products Chemistry, and Professor of Chemistry at the University of Illinois Urbana-Champaign.\n<\/p>\n<p>\n\u201cArrePath is pioneering a highly innovative approach to the discovery of anti-infectives with new mechanisms of action to address antimicrobial resistance that integrates machine learning and imaging technologies into the drug discovery process,\u201d said Lloyd Payne, PhD, ArrePath\u2019s CEO. \u201cProfessors Coley and Hergenrother together bring outstanding, visionary leadership in the application of artificial intelligence and machine learning in drug discovery and innovative strategies for the design of drugs to treat antibiotic resistant bacteria, respectively. We look forward to many contributions from them as we continue to build out our platform and advance our initial compounds.\u201d\n<\/p>\n<p>\nProfessors Coley and Hergenrother will join other members of the company\u2019s distinguished SAB, including, Zemer Gitai, PhD, ArrePath\u2019s scientific founder, SAB Chair, and Edwin Grant Conklin Professor of Biology at Princeton University; Barbara Engelhardt, PhD, Professor of Computational Biology at Stanford University; and Todd A. Black, PhD, Senior Director of Biology for the Global Alliance of TB Drug Development.\n<\/p>\n<p>\nConnor\u2019s research focuses on computational and experimental techniques to enable autonomous molecular discovery at the intersection of chemistry, data science, machine learning, with an emphasis on small molecule drug discovery. Key research areas in his laboratory include the design of new neural models for representation learning on molecules, data-driven synthesis planning, <i>in silico<\/i> strategies for predicting the outcomes of organic reactions, model-guided Bayesian optimization, and <i>de novo<\/i> molecular generation. Connor is a recipient of <i>C&amp;EN\u2019s<\/i> \u201cTalented Twelve\u201d award, <i>Forbes Magazine\u2019s<\/i> \u201c30 Under 30\u201d for Healthcare, the NSF CAREER Award, and the Bayer Early Excellence in Science Award. He received his B.S. in Chemical Engineering from Caltech and his Ph.D. in Chemical Engineering from MIT.\n<\/p>\n<p>\nPaul\u2019s research interests span the design, synthesis, and evaluation of organic molecules with novel biological properties, including novel anticancer and antibacterial compounds where his group has developed predictive guidelines for compound accumulation in Gram-negative pathogens; chemical biology and synthetic organic chemistry. His compound discovery work encompasses a variety of approaches, including natural product synthesis, synthesis of complex-and-diverse compounds, structure-based design, and high-throughput screening. Paul\u2019s research has been recognized through many awards, including the 2016 UCB-Ehrlich Award for Excellence in Medicinal Chemistry, the 2017 ACS Arthur C. Cope Scholar Award, and the Eli Lilly Award for Medicinal Chemistry. In 2020, he was named a Fellow of the National Academy of Inventors. Paul received his B.S. in chemistry from the University of Notre Dame and obtained his PhD at the University of Texas at Austin.\n<\/p>\n<p>\n<b>About ArrePath<\/b>\n<\/p>\n<p>\nArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections. The company\u2019s proprietary machine learning (ML)-based platform enables the rapid and efficient identification of anti-infective agents with new mechanisms of action at the outset of the discovery process, through a deep understanding and analysis of cell and pathogen behavior. The platform\u2019s proof-of-concept has been demonstrated in studies published in <span class=\"bwuline\"><i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cell.com%2Fcell%2Fpdf%2FS0092-8674%252820%252930567-5.pdf&amp;esheet=52972297&amp;newsitemid=20221118005045&amp;lan=en-US&amp;anchor=Cell&amp;index=1&amp;md5=a2221e21655bb63a7b47ef869ba2f003\" rel=\"nofollow noopener\" shape=\"rect\">Cell<\/a><\/i><\/span> by ArrePath\u2019s scientific founder, Zemer Gitai, Ph.D., Edwin Grant Conklin Professor of Biology at Princeton University. The company is funded by the Boehringer Ingelheim Venture Fund, Insight Partners, Innospark Ventures, Viva BioInnovator, Arimed Capital, PTX Capital, and Nor\u2019easter Ventures. Learn more at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.arrrepath.com&amp;esheet=52972297&amp;newsitemid=20221118005045&amp;lan=en-US&amp;anchor=www.arrepath.com&amp;index=2&amp;md5=3d2795f51bfb24c4a8e8a5db0b0ba069\" rel=\"nofollow noopener\" shape=\"rect\">www.arrepath.com<\/a> and follow us on Twitter @ArrePath.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nRobert Gottlieb<br \/>\n<br \/>RMG Associates, LLC<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#x72;&#111;&#x62;&#x65;&#114;t&#x40;&#114;m&#x67;&#x62;&#105;&#x6f;&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#114;&#x6f;&#98;&#x65;&#114;&#x74;&#64;&#x72;&#109;&#x67;&#98;&#x69;&#111;&#x2e;&#99;&#x6f;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 PRINCETON, N.J.&#8211;(BUSINESS WIRE)&#8211;ArrePath today announced that it has appointed two new members to its Scientific Advisory Board (SAB): Connor Coley, PhD, Henri Slezynger (1957) Career Development Assistant Professor in Chemical Engineering at MIT, and Paul Hergenrother, PhD, Kenneth L. Rinehart Jr. Endowed Chair in Natural Products Chemistry, and Professor of Chemistry at the University &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51040","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ArrePath Appoints Connor Coley, PhD, and Paul Hergenrother, PhD, to Scientific Advisory Board - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ArrePath Appoints Connor Coley, PhD, and Paul Hergenrother, PhD, to Scientific Advisory Board - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"\u00a0 PRINCETON, N.J.&#8211;(BUSINESS WIRE)&#8211;ArrePath today announced that it has appointed two new members to its Scientific Advisory Board (SAB): Connor Coley, PhD, Henri Slezynger (1957) Career Development Assistant Professor in Chemical Engineering at MIT, and Paul Hergenrother, PhD, Kenneth L. Rinehart Jr. Endowed Chair in Natural Products Chemistry, and Professor of Chemistry at the University ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-18T15:02:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221118005045\/en\/1641767\/21\/ArrePath_640x360_CAN_USE_THIS.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ArrePath Appoints Connor Coley, PhD, and Paul Hergenrother, PhD, to Scientific Advisory Board\",\"datePublished\":\"2022-11-18T15:02:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\\\/\"},\"wordCount\":616,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221118005045\\\/en\\\/1641767\\\/21\\\/ArrePath_640x360_CAN_USE_THIS.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\\\/\",\"name\":\"ArrePath Appoints Connor Coley, PhD, and Paul Hergenrother, PhD, to Scientific Advisory Board - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221118005045\\\/en\\\/1641767\\\/21\\\/ArrePath_640x360_CAN_USE_THIS.jpg\",\"datePublished\":\"2022-11-18T15:02:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221118005045\\\/en\\\/1641767\\\/21\\\/ArrePath_640x360_CAN_USE_THIS.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221118005045\\\/en\\\/1641767\\\/21\\\/ArrePath_640x360_CAN_USE_THIS.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ArrePath Appoints Connor Coley, PhD, and Paul Hergenrother, PhD, to Scientific Advisory Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ArrePath Appoints Connor Coley, PhD, and Paul Hergenrother, PhD, to Scientific Advisory Board - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/","og_locale":"en_US","og_type":"article","og_title":"ArrePath Appoints Connor Coley, PhD, and Paul Hergenrother, PhD, to Scientific Advisory Board - Pharma Trend","og_description":"\u00a0 PRINCETON, N.J.&#8211;(BUSINESS WIRE)&#8211;ArrePath today announced that it has appointed two new members to its Scientific Advisory Board (SAB): Connor Coley, PhD, Henri Slezynger (1957) Career Development Assistant Professor in Chemical Engineering at MIT, and Paul Hergenrother, PhD, Kenneth L. Rinehart Jr. Endowed Chair in Natural Products Chemistry, and Professor of Chemistry at the University ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-18T15:02:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221118005045\/en\/1641767\/21\/ArrePath_640x360_CAN_USE_THIS.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ArrePath Appoints Connor Coley, PhD, and Paul Hergenrother, PhD, to Scientific Advisory Board","datePublished":"2022-11-18T15:02:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/"},"wordCount":616,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221118005045\/en\/1641767\/21\/ArrePath_640x360_CAN_USE_THIS.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/","url":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/","name":"ArrePath Appoints Connor Coley, PhD, and Paul Hergenrother, PhD, to Scientific Advisory Board - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221118005045\/en\/1641767\/21\/ArrePath_640x360_CAN_USE_THIS.jpg","datePublished":"2022-11-18T15:02:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221118005045\/en\/1641767\/21\/ArrePath_640x360_CAN_USE_THIS.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221118005045\/en\/1641767\/21\/ArrePath_640x360_CAN_USE_THIS.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ArrePath Appoints Connor Coley, PhD, and Paul Hergenrother, PhD, to Scientific Advisory Board"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51040"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51040\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}